LOGO
LOGO

Breaking News

Deutsche Boerse Confirms 2026 Guidance

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News   | Join Us

Deutsche Boerse (DB1GN.DE,DB1.DE) said the company's outlook for the full year 2026 remains unchanged. The company noted that its first quarter was marked by high volatility and geopolitical uncertainty. Deutsche Boerse said it has achieved a strong operational performance.

Jens Schulte, CFO of Deutsche Börse Group, said: "With the good start to the year, we are fully on track to achieve our ambitious goals for the full year."

For the first quarter, net profit attributable to shareholders was 585 million euros compared to 525 million euros, a year ago, an increase of 11 percent. Earnings per share were 3.21 euros compared to 2.86 euros. Earnings per share before purchase price allocation allocations, or cash EPS, was 3.40 euros compared to 3.05 euros. EBITDA including treasury result rose by 10 percent to 1.01 billion euros. EBITDA excluding the treasury result increased by 18 percent to 803 million euros.

First quarter net revenue without treasury result rose by 12 percent to 1.43 billion euros. Net revenue including the treasury result grew by 9 percent to 1.64 billion euros.

At last close, shares of Deutsche Boerse were trading at 266.40 euros, down 0.11%.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

RELATED NEWS
Latest Updates on COVID-19